These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
553 related items for PubMed ID: 18342648
1. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database. Murphy PA, Brixner D. Contraception; 2008 Apr; 77(4):257-63. PubMed ID: 18342648 [Abstract] [Full Text] [Related]
2. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U, Dubois M. Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606 [Abstract] [Full Text] [Related]
3. [Oral contraception: disadvantages of estrogen reduction]. Denis C. Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238 [Abstract] [Full Text] [Related]
5. [How to choose an oral contraceptive in 1984]. Rozenbaum H. Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609 [Abstract] [Full Text] [Related]
7. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch. Jick SS, Jick H. Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227 [Abstract] [Full Text] [Related]
8. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Jick S, Kaye JA, Li L, Jick H. Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129 [Abstract] [Full Text] [Related]
9. [Oral contraception: advantages of estrogen reduction]. Cohen J. Contracept Fertil Sex (Paris); 1993 Jun; 21(6):489-94. PubMed ID: 12318239 [Abstract] [Full Text] [Related]
10. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC. Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220 [Abstract] [Full Text] [Related]
11. Hormonal contraception: state of the art and future perspectives. Benagiano G, Bastianelli C, Farris M. Minerva Ginecol; 2007 Jun; 59(3):241-70. PubMed ID: 17576403 [Abstract] [Full Text] [Related]
15. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene]. Belaisch J, Hommais-loufrani B. Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078 [Abstract] [Full Text] [Related]